That is not the bottom line. The financials of the company could crater the shares, even if the supplement is useful in pharmacology. Furthermore, it doesn't have to 'significantly' lower inflammation to be a good development, does it? And do we 'know' it is safe and well tolerated? Up to this point, maybe, but how about 10, 20 years from now? Also, the FDA thought Vioxx was safe enough to approve and market, until serious cardiovascular issues began surfacing years later. Of course, Merck actually withheld damning safety risk data in order to get it approved. Do you think "doctors" were involved in that cover-up? Doctors do make mistakes, have big egos which can cloud their judgement, etc.
Your reasoning leaves a lot to be desired, fwiw.
Ps. The money Mullen is able to raise will be directly at our expense, not his, whether you think he has it figured out or not.
